PharmaCyte Biotech, Inc. (PMCB)
0.4865
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.49
0.00 (0.00%)
After-Hours: 20:00
PharmaCyte Biotech Total Liabilities (Quarterly) : 11.77M for April 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 11.77M |
| January 31, 2026 | 16.47M |
| October 31, 2025 | 19.42M |
| July 31, 2025 | 1.519M |
| April 30, 2025 | 3.277M |
| January 31, 2025 | 3.578M |
| October 31, 2024 | 11.65M |
| July 31, 2024 | 17.15M |
| April 30, 2024 | 20.39M |
| January 31, 2024 | 22.47M |
| October 31, 2023 | 20.81M |
| July 31, 2023 | 20.40M |
| April 30, 2023 | 0.5866M |
| January 31, 2023 | 0.8278M |
| October 31, 2022 | 1.311M |
| July 31, 2022 | 1.089M |
| April 30, 2022 | 0.7044M |
| January 31, 2022 | 0.613M |
| October 31, 2021 | 0.1861M |
| July 31, 2021 | 0.925M |
| April 30, 2021 | 0.7248M |
| January 31, 2021 | 0.6487M |
| October 31, 2020 | 0.6647M |
| July 31, 2020 | 1.187M |
| April 30, 2020 | 1.078M |
| Date | Value |
|---|---|
| January 31, 2020 | 1.019M |
| October 31, 2019 | 0.8039M |
| July 31, 2019 | 0.6066M |
| April 30, 2019 | 0.7429M |
| January 31, 2019 | 0.4712M |
| October 31, 2018 | 0.6624M |
| July 31, 2018 | 0.8829M |
| April 30, 2018 | 0.6442M |
| January 31, 2018 | 0.8872M |
| October 31, 2017 | 0.567M |
| July 31, 2017 | 0.8657M |
| April 30, 2017 | 0.5802M |
| January 31, 2017 | 0.5783M |
| October 31, 2016 | 0.449M |
| July 31, 2016 | 0.4565M |
| April 30, 2016 | 0.6376M |
| January 31, 2016 | 1.065M |
| October 31, 2015 | 1.08M |
| July 31, 2015 | 1.156M |
| April 30, 2015 | 1.520M |
| January 31, 2015 | 0.3785M |
| October 31, 2014 | 0.2769M |
| July 31, 2014 | 0.3714M |
| April 30, 2014 | 0.3737M |
| January 31, 2014 | 0.4793M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agenus, Inc. | 378.54M |
| Amgen, Inc. | 83.95B |
| Anika Therapeutics, Inc. | 46.19M |
| BioCryst Pharmaceuticals, Inc. | 1.012B |
| Imunon, Inc. | 10.80M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 46.75M |
| Shareholders Equity (Quarterly) | 34.56M |
| Current Ratio | 45.28 |